Consolidated Statement of Cash Flows

(Unit: million yen)

  2020
december
2021
december
2022
december
2023
december
2024
december
Cash flow from operating activities  
Net income before income taxes 1,277 1,523 8,372 8,378 10,071
depreciation 3,431 3,181 2,828 2,641 2,744
Amortization of goodwill 409 406 411 252 363
Start-up cost amortization amount 713 - - - -
Impairment loss 883 2,038 1,319 0 -
Increase/decrease in allowance for doubtful accounts (△ indicates decrease) △9 8 △508 18 △45
Increase/decrease in bonus reserve (△ indicates decrease) △15 124 983 907 △856
Increase/decrease in directors' bonus reserves (△ indicates decrease) 39 41 29 163 △86
Increase/decrease in provision for loss on orders received (△ indicates decrease) △17 △4 1 △1 3
Increase (decrease) in retirement benefit liabilities 28 119 59 △28 △22
Increase/decrease in assets related to retirement benefits (△ indicates increase) △28 △11 △14 △30 △34
Increase/decrease in reserve for directors' retirement benefits (△ indicates decrease) 6 10 5 △9 △8
Increase/decrease in provision for product warranties (△ indicates decrease) △65 △13 △42 △3 △1
Increase/decrease in provision for losses on business of affiliated companies (△ indicates decrease) - - 323 △224 △35
Increase/decrease in provision for losses related to competition law (△ indicates decrease) - - - - 728
Increase/decrease in provision for losses related to voluntary product recalls (△ indicates decrease) - - - - 126
Interest and dividend income △125 △117 △104 △128 △138
Interest paid 241 162 151 151 306
Equity in earnings of affiliates (△ indicates profit) - - 6 16 -
Gain/loss on sale of investment securities (△ indicates gain) △980 △296 △95 △169 △25
Gain on negative goodwill △123 - - - -
Gain or loss on sale of fixed assets (△ indicates gain) △0 △1,169 △6,882 △2 △538
Loss on disposal of fixed assets 113 122 1,782 328 156
Valuation gains/losses on investment securities (△ indicates gains) 163 64 - - -
Put option liabilities written to non-controlling interests
Valuation profit/loss (△ is profit)
- - - - △578
Increase/decrease in accounts receivable (△ indicates increase) 1,324 △86 △1,735 △3,124 1,219
Increase/decrease in inventory assets (△ indicates increase) 414 △1,260 △138 197 △941
Increase/decrease in accounts payable (△ indicates decrease) △2,866 510 842 390 △10,312
Others 637 △563 35 477 △1,662
subtotal 5,451 4,790 7,630 10,202 429
Interest and dividends received 125 114 102 118 162
Interest payments △237 △164 △147 △137 △320
Settlement payment amount - - - - △400
Corporate tax payment or refund amount (△ indicates payment) △777 △1,966 △1,782 △3,862 △872
Cash flow from operating activities 4,561 2,774 5,804 6,321 △1,000
Cash flow from investing activities  
Expenditures for time deposits △1,665 △1,327 △1,533 △4,150 △1,392
Income from withdrawal of fixed term deposits 1,698 1,320 1,631 4,491 1,534
Expenditures for the acquisition of tangible fixed assets △1,729 △2,110 △4,145 △3,316 △3,146
Proceeds from sales of property, plant and equipment 614 2,160 9,633 52 586
Expenditures for the acquisition of intangible fixed assets - - - △1,235 △2,890
Expenditures for acquisition of investment securities △35 △862 △65 △540 △252
Proceeds from sales of investment securities 1,412 800 301 351 84
Net increase/decrease in short-term loans (△ indicates increase) - - - - 29
Long-term loan expenditures - - - - △4
Revenue from collection of long-term loans 2 2 0 0 0
Changes in the scope of consolidation
Expenditures for acquisition of subsidiary shares
48 - △36 - △928
Net increase/decrease in insurance reserves (△ indicates increase) △199 △246 △33 395 △608
Others △1,298 △908 △829 △59 △119
Cash flow from investing activities △1,152 △1,170 4,923 △4,012 △7,107
Cash flow from financing activities  
Net increase/decrease in short-term borrowings (△ indicates decrease) △2,359 △385 △100 △981 12,797
Proceeds from long-term borrowings 4,595 1,815 2,615 1,231 11,161
Repayment of long-term loans △2,369 △2,530 △2,288 △1,881 △3,459
Expenditures for redemption of corporate bonds △40 △40 △40 △60 △7
Net increase/decrease in treasury stock (△ indicates increase) 1 △0 △0 △0 △15,901
Expenditures for acquisition of treasury stock △175 - - - -
Proceeds from issuance of shares upon exercise of stock acquisition rights 45 - - - 4,069
Dividend payment amount △592 △586 △678 △1,675 △1,901
Dividends paid to non-controlling shareholders △0 △0 △0 △0 △0
No change in the scope of consolidation
Expenditures for acquisition of subsidiary shares
- - - △1 △360
Others △1,371 △930 △934 △778 △494
Cash flow from financing activities △2,267 △2,658 △1,426 △4,148 5,905
Effect of exchange rate changes on cash and cash equivalents △27 155 239 83 32
Increase/decrease in cash and cash equivalents (△ indicates decrease) 1,114 △900 9,541 △1,755 △2,170
Cash and cash equivalents at beginning of period 15,494 16,697 15,797 25,420 23,664
Due to change in the fiscal year end of consolidated subsidiaries
Increase/decrease in cash and cash equivalents (△ indicates decrease)
89 - 81    
Ending balance of cash and cash equivalents 16,697 15,797 25,420 23,664 21,494

CONTACT

For all inquiries, please click here.